📰 Abt News
Page 104 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
September 15, 2023
Apella Capital LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,447 shares of the healthcare product maker’s stock, valued at approximately $703,000. Several other hedge funds and other institutional investors have also added to […]
September 15, 2023
Greenfield Savings Bank boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,310 shares of the healthcare product maker’s stock after acquiring an additional 200 shares during […]
September 15, 2023
Fulton Bank N.A. boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,449 shares of the healthcare product maker’s stock after buying an additional 413 shares during the quarter. Fulton Bank N.A.’s […]
September 15, 2023
Park National Corp OH lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.1% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 378,627 shares of the healthcare product maker’s stock after selling 11,941 shares during the period. […]
September 15, 2023
Red Spruce Capital LLC boosted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,163 shares of the healthcare product maker’s stock after purchasing an additional 225 shares during the […]
September 15, 2023
MADDEN SECURITIES Corp decreased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 5.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,300 shares of the healthcare product maker’s stock after selling 120 shares during the period. MADDEN […]
September 15, 2023
Boltwood Capital Management lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,242 shares of the healthcare product maker’s stock after selling 175 shares during the period. Boltwood Capital Management’s holdings in […]
September 15, 2023
First Hawaiian Bank trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,866 shares of the healthcare product maker’s stock after selling 1,518 shares during the quarter. First Hawaiian Bank’s holdings in […]
September 15, 2023
First Hawaiian Bank lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 6.5% during the 2nd quarter, Holdings Channel reports. The firm owned 21,866 shares of the healthcare product maker’s stock after selling 1,518 shares during the period. First Hawaiian Bank’s holdings in Abbott Laboratories were worth $2,384,000 at the end of the […]
September 14, 2023
Arcblock (ABT) traded down 1.5% against the U.S. dollar during the 1 day period ending at 22:00 PM E.T. on September 13th. Arcblock has a total market cap of $7.21 million and approximately $106,815.65 worth of Arcblock was traded on exchanges in the last 24 hours. One Arcblock token can now be bought for about […]